Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

Alimera Sciences diskutieren

Alimera Sciences

WKN: A0Q78Q / Symbol: ALIM / Name: Alimera Sciences / Aktie / Pharmazeutika / Small Cap /

?
9,19 %

Einschätzung Buy
Rendite (%) -
Kursziel 8,28
Veränderung
Endet am 03.04.24

Alimera Sciences, Inc. (NASDAQ: ALIM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for ALIM provided by MarketBeat

Alimera Sciences, Inc. (NASDAQ: ALIM) was upgraded by analysts at Alliance Global Partners from a "neutral" rating to a "buy" rating.
Ratings data for ALIM provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 4,57
Veränderung
Endet am 14.08.24

Alimera Sciences, Inc. (NASDAQ: ALIM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for ALIM provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 9,23
Veränderung
Endet am 25.03.25

Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for ALIM provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 5,52
Veränderung
Endet am 16.05.25

Alimera Sciences, Inc. (NASDAQ: ALIM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for ALIM provided by MarketBeat